Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $177,580 - $211,555
-3,083 Reduced 34.91%
5,748 $393,000
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $429,539 - $510,520
8,831 New
8,831 $510,000
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $2.38 Million - $2.81 Million
-62,528 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $1.35 Million - $1.5 Million
-32,668 Reduced 34.32%
62,528 $2.71 Million
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $2.39 Million - $2.75 Million
62,070 Added 187.38%
95,196 $4.07 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $1.3 Million - $1.46 Million
-36,915 Reduced 52.7%
33,126 $1.28 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $190,446 - $241,117
5,745 Added 8.94%
70,041 $2.52 Million
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $2.21 Million - $2.72 Million
64,296 New
64,296 $2.46 Million
Q1 2019

May 15, 2019

SELL
$32.91 - $40.75 $2.56 Million - $3.17 Million
-77,730 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $2.47 Million - $3.03 Million
77,730 New
77,730 $2.75 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $1.93 Million - $2.46 Million
-71,740 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $1.81 Million - $2.05 Million
71,740 New
71,740 $1.96 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.